In contrast to the transmembrane proteoglycans discussed above, betaglycan, also known as TGFβ-receptor 3 (TGFβR3), has been associated with positive outcome in cancer patients (Nicolosi et al., 2015). This evidence concerns the gene TGFBR3 and cancer.